Literature DB >> 14574625

Cholesterol and tau protein--findings in Alzheimer's and Niemann Pick C's disease.

T G Ohm1, S Treiber-Held, R Distl, F Glöckner, B Schönheit, M Tamanai, V Meske.   

Abstract

Niemann Pick C (NPC), a fatal autosomal-recessive neurovisceral lipid storage disorder, is a juvenile dementia with massive nerve-cell loss and cytoskeletal abnormalities in cerebral neurons. These abnormalities consist of tangles of tau protein, which is otherwise highly soluble and usually stabilizes the microtubules. Immunologically and ultrastructurally similar tangles are seen some decades later in patients with Alzheimer's disease (AD). There is evidence that tangle-bearing cells in both diseases show higher levels of free (i. e. filipin-positive) cholesterol than adjacent tangle-free nerve cells. The cholesterol accumulates either in a more diffuse way (mainly in AD) or in granule-like accumulations (mainly in NPC). In NPC, neuron cholesterol may originate from sources other than the alimentary tract. Experiments with a NPC mouse model revealed that even in pure neuron cultures, the NPC -/- neurons accumulate free cholesterol in contrast to NPC-wt littermates, suggesting that the cholesterol is either synthesized by the neurons or liberated from degenerated ones before being taken up by the endosomal/lysosomal pathway. The accumulation of free cholesterol in the somata of NPC neurons is associated with a decrease of cholesterol levels in myelin sheaths. In terms of tau protein, NPC -/- mice exhibit higher levels of AT8-positive tau, suggesting that the phosphorylation-dependent mAb AT8 has detected a tau-epitope in a state considered to represent early stages of tangle formation. Concomitantly to the increase in free intracellular cholesterol, the rate-limiting enzyme in cholesterol and isoprenoid biosynthesis, HMG-CoA reductase, was found to be significantly reduced. Experimental blockade of the enzyme's activity by application of the lipid-lowering drug lovastatin showed subcellular shifts in tau phosphorylation as monitored with mAbs AT8, 12E8 and others. In summary, the data showed interesting similarities between NPC and AD suggesting some pathological metabolic pathway in common.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14574625     DOI: 10.1055/s-2003-43060

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  18 in total

1.  Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy.

Authors:  Sooyeon Lee; Yutaka Sato; Ralph A Nixon
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

Review 2.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

3.  Cyclodextrin has conflicting actions on autophagy flux in vivo in brains of normal and Alzheimer model mice.

Authors:  Dun-Sheng Yang; Philip Stavrides; Asok Kumar; Ying Jiang; Panaiyur S Mohan; Masuo Ohno; Kostantin Dobrenis; Cristin D Davidson; Mitsuo Saito; Monika Pawlik; Chunfeng Huo; Steven U Walkley; Ralph A Nixon
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

Review 4.  Cholesterol in Niemann-Pick Type C disease.

Authors:  Xiaoning Bi; Guanghong Liao
Journal:  Subcell Biochem       Date:  2010

5.  Prion-induced activation of cholesterogenic gene expression by Srebp2 in neuronal cells.

Authors:  Christian Bach; Sabine Gilch; Romina Rost; Alex D Greenwood; Marion Horsch; Glaucia N M Hajj; Susanne Brodesser; Axel Facius; Sandra Schädler; Konrad Sandhoff; Johannes Beckers; Christine Leib-Mösch; Hermann M Schätzl; Ina Vorberg
Journal:  J Biol Chem       Date:  2009-09-11       Impact factor: 5.157

Review 6.  Plasticity and the spread of Alzheimer's disease-like changes.

Authors:  Thomas G Ohm; Frauke Glöckner; Roland Distl; Stefanie Treiber-Held; Volker Meske; Bärbel Schönheit
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

Review 7.  Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up.

Authors:  Ralph A Nixon
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

Review 8.  Amyloid-independent mechanisms in Alzheimer's disease pathogenesis.

Authors:  Sanjay W Pimplikar; Ralph A Nixon; Nikolaos K Robakis; Jie Shen; Li-Huei Tsai
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

9.  Alterations in gene expression in mutant amyloid precursor protein transgenic mice lacking Niemann-Pick type C1 protein.

Authors:  Mahua Maulik; Gopal Thinakaran; Satyabrata Kar
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

10.  A genome-wide survey for prion-regulated miRNAs associated with cholesterol homeostasis.

Authors:  Judith Montag; Markus Brameier; Ann-Christin Schmädicke; Sabine Gilch; Hermann M Schätzl; Dirk Motzkus
Journal:  BMC Genomics       Date:  2012-09-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.